AnX Robotica, the leader in advanced gastrointestinal visualization technologies, is happy to announce a recent publication validating the clinical benefits of using ProScan, the first FDA cleared AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy. This significant milestone, which further validates the AI technology, firmly establishes NaviCam SB with ProScan as the most advanced technology in small bowel video capsule endoscopy.
The study, AI-assisted capsule endoscopy reading in suspected small bowel bleeding: a multicentre prospective study, published in Lancet Digital Health, was conducted across 14 European centers validating ProScan’s effectiveness in different clinical settings and supporting its generalizability and scalability. Overall, the findings demonstrated an increased diagnostic yield and significantly higher lesion detection rate. These findings suggest that integrating ProScan into clinical practice can enhance the diagnostic process for small bowel bleeding through more accurate and quicker readings, ultimately benefiting patient management and healthcare efficiency.
“ProScan is a groundbreaking AI-assisted reading tool that marks a significant leap forward in gastrointestinal diagnostics, stated Dr. Cristiano Spada, Professor of Gastroenterology at Gemelli Hospital in Rome, Italy. ProScan not only enhances the accuracy of small bowel bleeding detection but also dramatically reduces reading times, offering clinicians a powerful tool to improve patient outcomes efficiently.”
“This innovation underscores our continued commitment to advancing medical technology and supporting healthcare professionals in providing the best care possible, commented Stu Wildhorn, Vice President of Marketing and Product Management at AnX Robotica.”
Source: PRNewsWire
